Neurofibroma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neurofibroma}} | {{Neurofibroma}} | ||
{{CMG}}; {{AE}}{{S.M.}} {{SC}} | {{CMG}}; {{AE}} {{S.M.}}, {{SC}} | ||
==Overview== | ==Overview== | ||
[[Neurofibroma]] usually occurs between 20-40 years of [[age]], and [[Affect|affects]] [[men]] and women equally. However, [[Plexiform neurofibroma|plexiform neurofibromas]] are thought to be [[congenital defects]], hence, they occur earlier in [[life]]. | [[Neurofibroma]] usually occurs between 20-40 years of [[age]], and [[Affect|affects]] [[men]] and women equally. However, [[Plexiform neurofibroma|plexiform neurofibromas]] are thought to be [[congenital defects]], hence, they occur earlier in [[life]]. | ||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Age=== | ===Age=== | ||
* [[Neurofibroma]] usually [[Affect|affects]] individuals between 20 and 40 years of [[age]] | * [[Neurofibroma]] usually [[Affect|affects]] individuals between 20 and 40 years of [[age]]. | ||
* [[Plexiform neurofibroma]]s occur earlier in [[life]] and are thought to be [[congenital defects]]<ref name="Yamashiroya2002">[http://www.hawaii.edu/medicine/pediatrics/pedtext/s18c11.html "Case Based Pediatrics For Medical Students and Residents: Chapter XVIII.11. Neurofibromatosis", by Vince K. Yamashiroya, MD. August, 2002. Department of Pediatrics, University of Hawaii John A. Burns School of Medicine.]</ref> | * [[Plexiform neurofibroma]]s occur earlier in [[life]] and are thought to be [[congenital defects]].<ref name="Yamashiroya2002">[http://www.hawaii.edu/medicine/pediatrics/pedtext/s18c11.html "Case Based Pediatrics For Medical Students and Residents: Chapter XVIII.11. Neurofibromatosis", by Vince K. Yamashiroya, MD. August, 2002. Department of Pediatrics, University of Hawaii John A. Burns School of Medicine.]</ref> | ||
===Gender=== | ===Gender=== | ||
* [[Neurofibroma]] [[Affect|affects]] [[men]] and women equally | * [[Neurofibroma]] [[Affect|affects]] [[men]] and women equally. | ||
==References== | ==References== | ||
Latest revision as of 16:15, 1 November 2019
|
Neurofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neurofibroma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Neurofibroma epidemiology and demographics |
|
Risk calculators and risk factors for Neurofibroma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2], Shanshan Cen, M.D. [3]
Overview
Neurofibroma usually occurs between 20-40 years of age, and affects men and women equally. However, plexiform neurofibromas are thought to be congenital defects, hence, they occur earlier in life.
Epidemiology and Demographics
Age
- Neurofibroma usually affects individuals between 20 and 40 years of age.
- Plexiform neurofibromas occur earlier in life and are thought to be congenital defects.[1]
Gender
- Neurofibroma affects men and women equally.